sdAbs are unique type of antibodies derived from camelids and widely used as therapeutics, especially as building blocks for multi-specific antibodies. Our first session will explore phage display and single B-cell technologies for sdAb lead generation, comparing their key features.

To accelerate CMC development, ProBio introduced ExpressCMC—achieving an industry-leading 4-month timeline from DNA to tox batch using an innovative cell line platform. The second session will reveal how we make this possible for your process.